BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21294212)

  • 1. Evidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndrome.
    Menéndez-Arias L
    Rev Med Virol; 2011 Jan; 21(1):3-17. PubMed ID: 21294212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of xenotropic murine leukemia virus-related virus (XMRV) infection in chronic fatigue syndrome and prostate cancer.
    Mikovits JA; Huang Y; Pfost MA; Lombardi VC; Bertolette DC; Hagen KS; Ruscetti FW
    AIDS Rev; 2010; 12(3):149-52. PubMed ID: 20842203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of evidence for a role of xenotropic murine leukemia virus-related virus in the pathogenesis of prostate cancer and/or chronic fatigue syndrome.
    Hong P; Li J
    Virus Res; 2012 Jul; 167(1):1-7. PubMed ID: 22531412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Xenotropic murine leukaemia virus-related virus (XMRV) does not cause chronic fatigue.
    Robinson MJ; Erlwein O; McClure MO
    Trends Microbiol; 2011 Nov; 19(11):525-9. PubMed ID: 21978843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of xenotropic murine leukemia virus-related virus infection in different risk populations in Spain.
    Arredondo M; Hackett J; de Bethencourt FR; Treviño A; Escudero D; Collado A; Qiu X; Swanson P; Soriano V; de Mendoza C
    AIDS Res Hum Retroviruses; 2012 Sep; 28(9):1089-94. PubMed ID: 22206583
    [TBL] [Abstract][Full Text] [Related]  

  • 6. XMRV, prostate cancer and chronic fatigue syndrome.
    Kenyon JC; Lever AM
    Br Med Bull; 2011; 98():61-74. PubMed ID: 21551158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of xenotropic murine leukemia virus-related virus in blood donors in China.
    Mi Z; Lu Y; Zhang S; An X; Wang X; Chen B; Wang Q; Tong Y
    Transfusion; 2012 Feb; 52(2):326-31. PubMed ID: 21854397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenotropic murine leukemia virus-related virus does not pose a risk to blood recipient safety.
    Dodd RY; Hackett J; Linnen JM; Dorsey K; Wu Y; Zou S; Qiu X; Swanson P; Schochetman G; Gao K; Carrick JM; Krysztof DE; Stramer SL
    Transfusion; 2012 Feb; 52(2):298-306. PubMed ID: 22098340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenotropic murine leukaemia virus-related virus is not found in peripheral blood cells from treatment-naive human immunodeficiency virus-positive patients.
    Maggi F; Focosi D; Lanini L; Sbranti S; Mazzetti P; Macera L; Davini S; De Donno M; Mariotti ML; Antonelli G; Scatena F; Pistello M
    Clin Microbiol Infect; 2012 Feb; 18(2):184-8. PubMed ID: 21672082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of xenotropic murine leukemia virus-related virus in normal and retrovirus-infected blood donors.
    Qiu X; Swanson P; Tang N; Leckie GW; Devare SG; Schochetman G; Hackett J
    Transfusion; 2012 Feb; 52(2):307-16. PubMed ID: 22023235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The xenotropic murine leukemia virus-related retrovirus debate continues at first international workshop.
    Stoye JP; Silverman RH; Boucher CA; Le Grice SF
    Retrovirology; 2010 Dec; 7():113. PubMed ID: 21176195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human retrovirus XMRV in prostate cancer and chronic fatigue syndrome.
    Silverman RH; Nguyen C; Weight CJ; Klein EA
    Nat Rev Urol; 2010 Jul; 7(7):392-402. PubMed ID: 20517289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen-independent proliferation of LNCaP prostate cancer cells infected by xenotropic murine leukemia virus-related virus.
    Kakoki K; Kamiyama H; Izumida M; Yashima Y; Hayashi H; Yamamoto N; Matsuyama T; Igawa T; Sakai H; Kubo Y
    Biochem Biophys Res Commun; 2014 Apr; 447(1):216-22. PubMed ID: 24721431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No association of xenotropic murine leukemia virus-related virus with prostate cancer or chronic fatigue syndrome in Japan.
    Furuta RA; Miyazawa T; Sugiyama T; Kuratsune H; Ikeda Y; Sato E; Misawa N; Nakatomi Y; Sakuma R; Yasui K; Yamaguti K; Hirayama F
    Retrovirology; 2011 Mar; 8():20. PubMed ID: 21414229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of human xenotropic murine leukemia virus-related gammaretrovirus (XMRV) in Dutch prostate cancer patients.
    Verhaegh GW; de Jong AS; Smit FP; Jannink SA; Melchers WJ; Schalken JA
    Prostate; 2011 Mar; 71(4):415-20. PubMed ID: 20878949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. XMRV: usage of receptors and potential co-receptors.
    Setty MK; Devadas K; Ragupathy V; Ravichandran V; Tang S; Wood O; Gaddam DS; Lee S; Hewlett IK
    Virol J; 2011 Sep; 8():423. PubMed ID: 21896167
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of xenotropic murine leukemia virus-related virus by APOBEC3 proteins and antiviral drugs.
    Paprotka T; Venkatachari NJ; Chaipan C; Burdick R; Delviks-Frankenberry KA; Hu WS; Pathak VK
    J Virol; 2010 Jun; 84(11):5719-29. PubMed ID: 20335265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raltegravir is a potent inhibitor of XMRV, a virus implicated in prostate cancer and chronic fatigue syndrome.
    Singh IR; Gorzynski JE; Drobysheva D; Bassit L; Schinazi RF
    PLoS One; 2010 Apr; 5(4):e9948. PubMed ID: 20376347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of cerebrospinal fluid from chronic fatigue syndrome patients for multiple human ubiquitous viruses and xenotropic murine leukemia-related virus.
    Schutzer SE; Rounds MA; Natelson BH; Ecker DJ; Eshoo MW
    Ann Neurol; 2011 Apr; 69(4):735-8. PubMed ID: 21472770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No detectable XMRV in subjects with chronic fatigue syndrome from Quebec.
    Cool M; Bouchard N; Massé G; Laganière B; Dumont A; Hanna Z; Phaneuf D; Morisset R; Jolicoeur P
    Virology; 2011 Nov; 420(1):66-72. PubMed ID: 21925693
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.